Effect of Astaxanthin Supplementation on Plasma Malondialdehyde Levels and NIHSS of Stroke Patients
Status:
Completed
Trial end date:
2010-06-09
Target enrollment:
Participant gender:
Summary
This is an interventional randomized, controlled trial in analyzing the effects of
astaxanthin supplementation on plasma malondialdehyde levels and NIHSS of acute ischemic
stroke patients. According to published studies, it was hypothesized that acute ischemic
stroke patients who were given astaxanthin would have lower plasma malondialdehyde levels and
lower NIHSS score compared to the control group.